Appendix B: Panel Roster and Financial Disclosures
Candidiasis
Member | Institution | Financial Disclosure | |
---|---|---|---|
Company | Relationship | ||
Michail Lionakis* | National Institutes of Health | None | N/A |
Michael Mansour | Massachusetts General Hospital | GenMark Diagnostics | Scientific Advisory Board |
Genetech Thermo Fisher Scientific |
Research Support (paid to institution) | ||
Sorrento Therapeutics | Equity Interest | ||
Vericel Pulsethera NED Biosystems Day Zero Diagnostics Clear Creek Bio |
Consultant | ||
Jeniel Nett | University of Wisconsin–Madison, School of Medicine and Public Health | None | N/A |
Sanjay Revankar | Wayne State University, School of Medicine | Merck | Consultant |
Jack Sobel | Wayne State University, School of Medicine | None | N/A |
* Group lead Note: Members are required to update disclosures annually and to notify guideline staff of any relevant changes in status during the interim. |
Download Guidelines
- Section OnlyPDF (156.41 KB)
- Full GuidelinePDF (5.47 MB)
- Tables OnlyPDF (1.01 MB)